  {"id":42528,"date":"2019-05-14T11:00:16","date_gmt":"2019-05-14T02:00:16","guid":{"rendered":"http:\/\/www.veeva.com\/jp\/?p=42528"},"modified":"2019-05-14T10:52:57","modified_gmt":"2019-05-14T01:52:57","slug":"spark-therapeutics-ceo-and-former-merck-president-to-keynote-veeva-commercial-medical-summit","status":"publish","type":"post","link":"https:\/\/www.veeva.com\/jp\/news\/spark-therapeutics-ceo-and-former-merck-president-to-keynote-veeva-commercial-medical-summit\/","title":{"rendered":"Spark Therapeutics\u793eCEO\u3068Merck\u793e\u524d\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u304c³Ô¹Ï±¬ÁÏ Commercial &#038; Medical Summit\u3067\u57fa\u8abf\u8b1b\u6f14"},"content":{"rendered":"<p style=\"text-align: right;\">2019\u5e745\u670814\u65e5<\/p>\n<p style=\"text-align: right;\">³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n<p>&nbsp;<\/p>\n<p>³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b ³Ô¹Ï±¬ÁÏ)\u306f\u3001Merck\u793e\u30b0\u30ed\u30fc\u30d0\u30eb\u30fb\u30d2\u30e5\u30fc\u30de\u30f3\u30fb\u30d8\u30eb\u30b9\u90e8\u9580\u306e\u524d\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3067\u3042\u308a\u73fe\u5728\u306fCEO\u306e\u76f8\u8ac7\u5f79\u3092\u52d9\u3081\u308bAdam H. Schechter\u6c0f\u3068\u3001Spark Therapeutics\u793e\u306e\u5171\u540c\u5275\u696d\u8005\u517cCEO\u3067\u3042\u308bJeffrey D. Marrazzo\u6c0f\u304c\u30012019 ³Ô¹Ï±¬ÁÏ Commercial &amp; Medical Summit\u3067\u57fa\u8abf\u8b1b\u6f14\u306b\u767b\u58c7\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u5148\u898b\u306e\u660e\u3092\u304a\u6301\u3061\u306e\u30ea\u30fc\u30c0\u30fc\u3067\u3042\u308b\u4e21\u6c0f\u306b\u3001\u300c\u30d7\u30ec\u30b7\u30b8\u30e7\u30f3\u30fb\u30e1\u30c7\u30a3\u30b7\u30f3\uff08\u7cbe\u5bc6\u533b\u7642\uff09\u300d\u3068\u300c\u4fa1\u5024\u306b\u57fa\u3065\u304f\u533b\u7642\u300d\u306e\u6642\u4ee3\u306b\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30e2\u30c7\u30eb\u306f\u3069\u3046\u9032\u5316\u3059\u3079\u304d\u304b\u306b\u3064\u3044\u3066\u3001\u8b1b\u6f14\u3057\u3066\u3044\u305f\u3060\u304d\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f<strong><a href=\"https:\/\/www.veeva.com\/resources\/veeva-vault-promomats-selected-by-roche-for-digital-asset-management-and-content\/\">\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n<p>&nbsp;<\/p>\n<p>Schechter\u6c0f\u306b\u306f\u30012019\u5e745\u670814\u65e5\u306e\u30c8\u30fc\u30af\u30a4\u30d9\u30f3\u30c8\u3067\u3082\u3001\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30e2\u30c7\u30eb\u306e\u9032\u5316\u3084\u3001\u60a3\u8005\u306b\u9769\u65b0\u7684\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u3082\u305f\u3089\u3059\u53ef\u80fd\u6027\u306b\u3064\u3044\u3066\u8a9e\u3063\u3066\u3044\u305f\u3060\u304d\u307e\u3059\u300230\u5e74\u306b\u308f\u305f\u3063\u3066\u696d\u754c\u3092\u727d\u5f15\u3057\u3066\u304d\u305fSchechter\u6c0f\u306f\u3001\u30b0\u30ed\u30fc\u30d0\u30eb\u5e02\u5834\u3068\u533b\u7642\u5206\u91ce\u306b\u304a\u3051\u308b\u5e45\u5e83\u3044\u7d4c\u9a13\u3092\u304a\u6301\u3061\u3067\u3059\u3002<\/p>\n<p>\u7fcc\u65e5\u306fMarrazzo\u6c0f\u306b\u3001FDA\u306e\u627f\u8a8d\u3092\u5f97\u305f\u907a\u4f1d\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u521d\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u30921\u5e74\u304b\u3051\u3066\u5546\u54c1\u5316\u3057\u305f\u969b\u306e\u3054\u7d4c\u9a13\u3092\u8a9e\u3063\u3066\u3044\u305f\u3060\u304d\u307e\u3059\u3002Spark Therapeutics\u793e\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u3088\u3063\u3066\u3001\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u30e2\u30c7\u30eb\u304c\u518d\u5b9a\u7fa9\u3055\u308c\u3001\u533b\u7642\u4fdd\u967a\u652f\u6255\u8005\u3084\u533b\u7642\u63d0\u4f9b\u8005\u3001\u305d\u3057\u3066\u60a3\u8005\u3068\u306e\u95a2\u308f\u308a\u65b9\u3092\u6539\u5584\u3059\u308b\u30c1\u30e3\u30f3\u30b9\u304c\u751f\u307f\u51fa\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>2019 ³Ô¹Ï±¬ÁÏ Commercial &amp; Medical Summit\u306f2019\u5e745\u670813\uff5e15\u65e5\u306b\u30da\u30f3\u30b7\u30eb\u30d9\u30cb\u30a2\u5dde\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u3067\u958b\u50ac\u3055\u308c\u307e\u3059\u30021,700\u540d\u3092\u8d85\u3048\u308b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306e\u30d7\u30ed\u30d5\u30a7\u30c3\u30b7\u30e7\u30ca\u30eb\u3084\u5c02\u9580\u5bb6\u306e\u7686\u69d8\u306e\u3054\u6765\u5834\u304c\u898b\u8fbc\u307e\u308c\u3066\u304a\u308a\u3001\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u3068\u30e1\u30c7\u30a3\u30ab\u30eb\u306b\u95a2\u3057\u3066\u306f\u3001\u696d\u754c\u6700\u5927\u898f\u6a21\u306e\u30a4\u30d9\u30f3\u30c8\u3068\u306a\u308b\u4e88\u5b9a\u3067\u3059\u3002<\/p>\n<p>11\u5e74\u76ee\u3092\u8fce\u3048\u308b\u3053\u306e\u30a4\u30d9\u30f3\u30c8\u306b\u306f\u300158\u540d\u306e\u5c02\u9580\u5bb6\u306b\u3088\u308b124\u306e\u30bb\u30c3\u30b7\u30e7\u30f3\u304c\u7528\u610f\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u30bb\u30c3\u30b7\u30e7\u30f3\u306b\u53c2\u52a0\u3044\u305f\u3060\u304f\u5c02\u9580\u5bb6\u306f\u3001\u3044\u305a\u308c\u3082\u4e16\u754c\u30c8\u30c3\u30d7\u30af\u30e9\u30b9\u306e\u88fd\u85ac\u4f01\u696d\u3084\u65b0\u8208\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306e\u65b9\u3005\u3067\u3059\u3002\u4f8b\u3048\u3070\u3001AbbVie\u793e\u3001Alexion\u793e\u3001Allergan\u793e\u3001Amgen\u793e\u3001Antares Pharma\u793e\u3001AstraZeneca\u793e\u3001Biogen\u793e\u3001Boehringer Ingelheim\u793e\u3001Bristol-Myers Squibb\u793e\u3001EMD Serono\u793e\u3001Genentech\u793e\u3001GSK\u793e\u3001Insmed\u793e\u3001Karyopharm\u793e\u3001Loxo Oncology\u793e\u3001Mallinckrodt\u793e\u3001MannKind Corporation\u793e\u3001Merck\u793e\u3001Novartis\u793e\u3001Paratek Pharmaceuticals\u793e\u3001Roche Diagnostics\u793e\u3001Sanofi\u793e\u3001Sarepta Therapeutics\u793e\u3001Upsher-Smith\u793e\u3001Xeris Pharmaceuticals\u793e\u3001Zimmer Biomet\u793e\u306a\u3069\u3067\u3059\u3002<\/p>\n<p>\u4eca\u5e74\u306e\u30a4\u30d9\u30f3\u30c8\u306f\u30b5\u30fc\u30d3\u30b9\u3001\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30b3\u30f3\u30c6\u30f3\u30c4\u306e\u4e3b\u8981\u306a\u30d1\u30fc\u30c8\u30ca\u30fc\u4f01\u696d34\u793e\u306b\u3088\u308b\u5f8c\u63f4\u306e\u3082\u3068\u3067\u5b9f\u65bd\u3055\u308c\u307e\u3059\u3002\u30d7\u30e9\u30c1\u30ca\u30b9\u30dd\u30f3\u30b5\u30fc\u306fAktana\u793e\u3001Cognizant\u793e\u3001Mavens\u793e\u3001Qlik\u793e\u3001Salesforce\u793e\u3001ZS Associates\u793e\u3067\u3059\u3002\u30b4\u30fc\u30eb\u30c9\u30b9\u30dd\u30f3\u30b5\u30fc\u306fAfore LLC\u793e\u3001FGS\u793e\u306e\u5b50\u4f1a\u793e\u3067\u3042\u308bBioPharma Graphic Services\u793e\u3001BusinessOne Technologies\u793e\u3001C3i Solutions\u793e\u3001Capgemini\u793e\u3001Conexus Solutions\u793e\u3001Cvent\u793e\u3001Eagle Productivity Solutions\u793e\u3001Framework Solutions\u793e\u3001HealthSTAR Strategic Engagements\uff08HSE\uff09\u793e\u3001iDetailAid\u793e\uff08Huron Solution\u5098\u4e0b\uff09\u3001Intouch Solutions\u793e\u3001Klick Health\u793e\u3001Knipper\u793e\u3001LPW Training\u793e\u3001Microsoft\u793e\u3001MMIT\u793e\u3001OwnBackup\u793e\u3001Physicians World\u793e\u3001RxS LLC\u793e\u3001Safeguard Cyber\u793e\u3001SCIO Health Analytics\u793e\u3001Xpediant Digital\u793e\u3067\u3059\u3002\u30b7\u30eb\u30d0\u30fc\u30b9\u30dd\u30f3\u30b5\u30fc\u306fBionical\u793e\u3001iDetailing Creatives\u793e\u3001Pixacore\u793e\u3001Publicis Health\u793e\u3001RMH\u793e\u3067\u3059\u3002<\/p>\n<p>\u3053\u306e\u30a4\u30d9\u30f3\u30c8\u306b\u306f³Ô¹Ï±¬ÁÏ\u306e\u304a\u5ba2\u69d8\u304a\u3088\u3073\u3054\u62db\u5f85\u5ba2\u306e\u7686\u69d8\u306b\u3054\u53c2\u52a0\u3044\u305f\u3060\u3051\u307e\u3059\u3002\u307e\u305f\u3001\u3054\u767b\u9332\u3068\u30a2\u30b8\u30a7\u30f3\u30c0\u306e\u3054\u78ba\u8a8d\u306f<strong><a href=\"https:\/\/www.veeva.com\/events\/commercial-summit\/\">veeva.com\/Summit<\/a><\/strong>\u304b\u3089\u884c\u3063\u3066\u3044\u305f\u3060\u3051\u307e\u3059\u3002<\/p>\n<p><strong>Adam H. Schechter<\/strong><strong>\u6c0f\u306b\u3064\u3044\u3066<\/strong><\/p>\n<p>Merck\u793e\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\uff06\u30de\u30fc\u30b1\u30c6\u30a3\u30f3\u30b0\u90e8\u9580\u3067\u3042\u308bGlobal Human Health\u30672010\uff5e2018\u5e74\u306b\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u3092\u52d9\u3081\u305fSchechter\u6c0f\u306f\u3001Merck\u793e\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u90e8\u9580\u306e\u767a\u5c55\u306b\u5c3d\u529b\u3055\u308c\u3001\u540c\u793e\u3067\u306f\u533b\u85ac\u54c1\u3068\u30ef\u30af\u30c1\u30f3\u3092\u4e16\u754c\u4e2d\u306e\u4eba\u3005\u306b\u5c4a\u3051\u3089\u308c\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3057\u305f\u3002\u540c\u6c0f\u306fMerck\u793e\u306e\u30b3\u30de\u30fc\u30b7\u30e3\u30eb\u90e8\u9580\u306b\u304a\u3044\u306630\u5e74\u9593\u306b\u308f\u305f\u308a\u6210\u679c\u3092\u4e0a\u3052\u3001Merck\u793e\u3068Schering-Plough\u306e\u7d71\u5408\u3092\u4e3b\u5c0e\u3057\u3066\u3053\u3089\u308c\u307e\u3057\u305f\u3002\u3053\u306e\u7d71\u5408\u306f\u3001\u4eca\u65e5\u306eMerck\u793e\u3092\u7bc9\u304f\u3046\u3048\u3067\u306e\u91cd\u8981\u306a\u7bc0\u76ee\u3068\u306a\u308a\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u540c\u6c0f\u306f\u6b27\u5dde\u88fd\u85ac\u56e3\u4f53\u9023\u5408\u4f1a\uff08EFPIA\uff09\u306e\u5f79\u54e1\u3092\u52d9\u3081\u305f\u7d4c\u9a13\u3082\u304a\u6301\u3061\u3067\u3059\u3002<\/p>\n<p><strong>Jeffrey D. Marrazzo<\/strong><strong>\u6c0f\u306b\u3064\u3044\u3066<\/strong><\/p>\n<p>Marrazzo\u6c0f\u306fSpark Therapeutics\u793e\u306e\u8a2d\u7acb\u3068\u6210\u9577\u3092\u4e3b\u5c0e\u3057\u3066\u3053\u3089\u308c\u307e\u3057\u305f\u3002\u30d5\u30a3\u30e9\u30c7\u30eb\u30d5\u30a3\u30a2\u5c0f\u5150\u75c5\u9662\u5185\u306e\u7814\u7a76\u30bb\u30f3\u30bf\u30fc\u3067\u3042\u3063\u305f\u540c\u793e\u306f\u3001\u5546\u7528\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u624b\u304c\u3051\u308b\u5b8c\u5168\u7d71\u5408\u578b\u306e\u4f01\u696d\u306b\u307e\u3067\u767a\u5c55\u3057\u3001\u73fe\u5728\u306f\u6cbb\u7642\u6cd5\u5019\u88dc\u3092\u72ec\u5275\u7684\u306a\u65b9\u6cd5\u3067\u767a\u898b\u3001\u958b\u767a\u3001\u63d0\u4f9b\u3059\u308b\u3053\u3068\u3067\u3001\u4e0d\u53ef\u907f\u3068\u898b\u3089\u308c\u3066\u3044\u305f\u907a\u4f1d\u5b50\u75be\u60a3\u306b\u6311\u3093\u3067\u3044\u307e\u3059\u3002Spark Therapeutics\u793e\u306f\u3001Marrazzo\u6c0f\u306e\u4e3b\u5c0e\u306e\u4e0b\u3067\u3001\u907a\u4f1d\u6027\u773c\u75be\u60a3\u306b\u5bfe\u3059\u308b\u521d\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u3064\u3044\u3066\u7c73\u56fd\u3068EU\u306e\u4e21\u65b9\u3067\u85ac\u4e8b\u627f\u8a8d\u3092\u5f97\u3066\u3001\u305d\u306e\u75be\u60a3\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u7c73\u56fd\u3067\u521d\u3081\u3066\u958b\u59cb\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001\u540c\u793e\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306b\u304a\u3051\u308b\u4eba\u4f53\u306b\u3088\u308b\u30b3\u30f3\u30bb\u30d7\u30c8\u8a3c\u660e\u3092\u7db2\u819c\u3068\u809d\u81d3\u306e\u4e21\u65b9\u306b\u3064\u3044\u3066\u78ba\u7acb\u3057\u307e\u3057\u305f\u3002Spark Therapeutics\u793e\u306fMIT\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30ec\u30d3\u30e5\u30fc\u306e\u300c\u6700\u3082\u30b9\u30de\u30fc\u30c8\u306a\u4f01\u696d50\u793e\u300d\u306e\u4e0a\u4f4d10\u793e\u306b2\u5ea6\u9078\u3070\u308c\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u30d5\u30a1\u30b9\u30c8\u30fb\u30ab\u30f3\u30d1\u30cb\u30fc\u8a8c\u3067\u3082\u30012018\u5e74\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u696d\u754c\u306b\u304a\u3051\u308b\u30c8\u30c3\u30d7\u30af\u30e9\u30b9\u306e\u9769\u65b0\u7684\u306a\u4f01\u696d\u3068\u3057\u3066\u9078\u51fa\u3055\u308c\u3066\u3044\u307e\u3059\u3002Marrazzo\u6c0f\u306fTwitter\u306b@JeffMarrazzo\u3068\u3044\u3046\u30a2\u30ab\u30a6\u30f3\u30c8\u3092\u958b\u8a2d\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>&nbsp;<\/p>\n<p><strong>\u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong><br \/>\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067700\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001<strong><a href=\"https:\/\/veeva.com\/jp\/\" target=\"_blank\" rel=\"noopener noreferrer\">\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n<p><strong>\u3010Forward-looking Statements\u3011<\/strong><br \/>\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended January 31, 2018. This is available on the company\u2019s website at <a href=\"https:\/\/www.veeva.com\/\">www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at <a href=\"http:\/\/www.sec.gov\/\">www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>2019\u5e745\u670814\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e &nbsp; ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751&hellip;<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42528","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42528"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42528"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42528\/revisions"}],"predecessor-version":[{"id":42530,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42528\/revisions\/42530"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}